two methyl, four methylene (two oxygen-bearing), five methine (three oxygenated, one olefinic) and four quaternary (one carbonyl, three olefinic) carbons. And particularly, the characteristic carbon signal (d C 196.6) observed in 13 C-NMR spectrum and IR absorption at 1676 cm Ϫ1 indicated the presence of a,b-unsaturated carbonyl. These spectroscopic features suggested that 1 was a sesquiterpene with an a,b-unsaturated carbonyl group. Furthermore, the correlation spectroscopy (gCOSY) spectrum revealed the correlations in a sequence of three methines at d H 4.65 (1H, br s, H-8), 4.15 (1H, d like, Jϭ2.0 Hz, H-7) and 2.44 (1H, dd, Jϭ2.0, 9.0 Hz, H-6), suggesting that H-7 coupled with the signals of H-6 and H-8, and together with the crucial 1 H- 13 C long-range correlations from H-6 to C-4 (d C 136.3), C-5 (d C 196.6), C-7 (d C 75.9) and C-8 (d C 70.2) and from H-8 to C-4, C-6, C-7 and C-9 (d C 159.7), which were observed in the heteronuclear multiple bond connectivity (HMBC) spectrum of 1 (Fig. 2) , displayed the presence of a six-membered a,b-unsaturated ketone ring. Observation of cross-peak in the HMBC spectrum from H-11 of the prenyl substituent to C-5 and C-7 proved that the prenyl unit was connected to C-6. On the basis of detailed analyses of 1 H-NMR, 13 C-NMR, DEPT, gCOSY, heteronuclear single quantum coherence (HSQC), HMBC spectra, all proton and carbon signals were assigned.
The absolute configuration of 1 was elucidated by analyses of nuclear Overhauser effect (NOE) difference experiments and CD data. In the NOE difference spectrum experiment (Fig. 3) , the enhancement of H-6 and H-8 when H-7 irradiated suggested the syn-orientation of the hydroxyl groups at 1542 Vol. 59, No. 12 C-7 and C-8 and prenyl unit at C-6. The enhancement of H10a as irradiation of H-8 and enhancement of H-10b upon irradiation of H-3 supported that 3-OH and 8-OH were opporiented. Molecular modeling indicated that the cyclohexenone moiety of the ring system possessed a twisted halfchair conformation for the lowest energy conformational isomer of 1, suggesting that the CD octant rule is applicable for determining the absolute configuration of the cyclohexenone moiety. 9, 10) In the CD spectrum of 1, a negative Cotton effect at 326 nm for a n-p* transition and a positive Cotton effect at 255 nm for a p-p* transition suggested the 3S,6S,7R,8S configuration of 1 (Fig. 4) . On the basis of the empirical rule of Snatzke's method (the dimolybdenum method), 11, 12) in the Mo 2 (AcO) 4 -induced CD spectrum of 1, a negative Cotton effect at 317 nm and positive Cotton effects at 352 nm further supported the 3S,6S configuration of 1. Therefore, 1 was identified as (ϩ)-(3S,6S,7R,8S)-periconone A as shown in Fig. 1 .
Compound 2 was isolated as a pale yellow oil. The molecular formula was determined to be C 10 (Table 1 ) and DEPT spectra gave 10 carbon resonances, including two methyl, one oxygen-bearing methylene, four methine (one oxygenated, one olefinic) and three quaternary (one carbonyl, one olefinic) carbons. These data indicated that 2 was a monoterpene with carene skeleton.
13) The 1 H-and 13 C-NMR spectra of 2 were similar to those of (ϩ)-trans-car-2-en-4-ol (2a), 13) except the absence of a methyl and the presence of a lactone moiety (d C 172.2), which was cyclized with C-4 and C-8, as supported by HMBC correlation between H-4 and C-8.
The configuration of 2 was assigned by the NOE difference and CD spectroscopic data. In the NOE difference spectrum (Fig. 3) , irradiation of H 3 -10 enhanced H-1 and H-6 and irradiation of H-4 gave an enhancement of H-6, suggesting that these protons (H-1, H-4, H-6) were syn-oriented. The CD spectrum of 2 exhibited a positive Cotton effect at 203 nm and a negative Cotton effect at 228 nm, supporting the 1R,4R,6S,7S configuration for 2 on the basis of the lactone octant rule [14] [15] [16] (Fig. 4) . Consequently, 2 was determined to be (Ϫ)-(1R,4R,6S,7S)-2-caren-4,8-olide.
The hypothetic biosynthesis pathway for 2 was shown in Fig. 5 . The biogenetic origin of 2 seems to be a carene monoterpenoid, which would be transformed into compound 2 by several oxidations and lactonization.
The anti-tumor activities against six human tumor cell lines (HCT-8, Bel-7402, BGC-823, A549, A2780 and MCF-7) were also evaluated. Unfortunately, the two compounds displayed low anti-tumor activities with IC 50 exceeding 10 Ϫ5 M.
Experimental
General Experimental Procedures Optical rotations were recorded on a Perkin-Elmer Model-343 polarimeter. IR spectra were determined on a Thermo Nicolet 5700 FT-IR microscope spectrometer. UV spectra were obtained on a Shimadzu UV-160 spectrophotometer. ESI-MS and HR-ESI-MS were measured on a Q-trap mass spectrometer. NMR spectra were obtained on a Bruker ARX-500 at 500 MHz ( .0-6.3; the media were autoclaved at 121°C for 30 min) at 4°C. The cultivation was performed in Erlenmeyer flasks (1000 ml) containing 400 ml of PDA liquid medium on a shaker at 130 rpm at 25°C for 10 d. The cultures were filtered under reduced pressure to afford the filtrate and mycelia. The filtrate (140 l) was applied to a Amberlite XAD-16 macroporous adsorbent resin column by eluting with H 2 O and 70% EtOH, successively. The 70% EtOH residue (63.2 g) was re-suspended in H 2 O followed by extracted with EtOAc. The EtOAc extract was evaporated under reduced pressure to yield 24.9 g of residue, which was subjected to silica gel CC eluting with a CHCl 3 -CH 3 OH gradient (100 : 0-0 : 100, v/v) to produce twelve fractions on the basis of TLC analysis. Fraction 4 was further fractionated via silica gel CC, eluting with CHCl 3 -CH 3 OH (100 : 2-50 : 50, v/v) to obtain five fractions (D 1 -D 5 ), the fraction D 2 (1.2 g) was subjected to CC over Sephadex LH-20 (CHCl 3 -CH 3 OH, 50 : 50, v/v) and normal phase semi-preparative HPLC using a mobile phase of nhexane-EtOAc (75 : 25, v/v) to afford 2 (5.7 mg, t R 11.62 min). tamine, 100 units/ml of penicillin, and 100 mg/ml of streptomycin. Cultures were incubated at 37°C in 5% CO 2 in air. HCT-8, Bel-7402, BGC-823, A549, A2780 and MCF-7 cells (1.5ϫ10 3 ) were seeded in 96-well tissue culture plates, and 100 ml of cell suspension was placed in each well. After 24 h, 100 ml of dimethyl sulfoxide (DMSO) solution containing the test compounds was added to give final concentrations of 0.01-10 mmol/ml; 100 ml of DMSO was added into control wells. The cells were treated with various concentrations of the test compounds for 96 h, and then cell growth was evaluated by an 3-[4,5-dimethylthiazol-2-yl]-2.5-diphenyltetrazolium bromide (MTT) assay procedure. A 100 ml aliquot of 0.5 mg/ml MTT in RPMI 1640 was added to every well, and the plate was reincubated in 5% CO 2 in air for 4 h at 37°C. The plate was then centrifuged to precipitate cells and formazan. An aliquot of 150 ml of DMSO was added to dissolve the formazan crystals. The plate was mixed on a microshaker for 10 min and then read on a microplate reader at 570 nm. All compounds were tested at six concentrations, and each concentration of the compounds was tested in three parallel wells. A dose-response curve was plotted for each compound, and the IC 50 value was calculated as the concentration of the test compound resulting in 50% reduction of optical density compared with the positive control (paclitaxel).
